Bank of America has revised its price target for Bausch Health Companies Inc. (BHC, Financial), bringing it down to $5 from a previous target of $7, while maintaining an Underperform rating on the stock. This adjustment comes as part of the firm's analysis of Q1 earnings expectations within its commercial-stage biopharmaceutical coverage.
According to BofA, the first quarter is typically the most challenging period for this sector due to various seasonal dynamics. Consequently, many companies are often afforded the benefit of the doubt, with the expectation that their growth and results will become more robust in the latter half of the year.
BofA also highlighted that macroeconomic factors, particularly concerns regarding pharmaceutical tariffs, may overshadow the performance of companies like Bausch Health in the first quarter. The financial community might, therefore, pay closer attention to these broader issues than to the detailed quarterly outcomes.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 6 analysts, the average target price for Bausch Health Companies Inc (BHC, Financial) is $8.58 with a high estimate of $12.00 and a low estimate of $7.00. The average target implies an upside of 77.52% from the current price of $4.84. More detailed estimate data can be found on the Bausch Health Companies Inc (BHC) Forecast page.
Based on the consensus recommendation from 6 brokerage firms, Bausch Health Companies Inc's (BHC, Financial) average brokerage recommendation is currently 3.2, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Bausch Health Companies Inc (BHC, Financial) in one year is $8.80, suggesting a upside of 82.01% from the current price of $4.835. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Bausch Health Companies Inc (BHC) Summary page.
